German biotech startup Paion has been shepherding through trials a geneticallyengineered version of a protein called desmoteplase, found in the saliva of vampire bats.
Existing drug regimens are based on various geneticallyengineered versions of the natural immune system protein alpha interferon combined with a second chemical, ribavirin.